|
⚲
|
| Keyboard |
| Gary Lyons | |
|---|---|
| Firm | |
| Address | 19900 MacArthur Boulevard Suite 550 Irvine, CA 92612 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Eledon Pharmaceuticals Inc | 021-482292 | Director | 35.0 M | ||
| Brickell Biotech Inc | 021-448413 | Director | 0.0 M of 0.0 M |
||
| Novus Therapeutics Inc | 021-376405 | Director | 108.1 M of 108.1 M |
||
| Novus Therapeutics Inc | 021-359033 | Director | 0.9 M of 5.8 M |
||
| Novus Therapeutics Inc | 021-339368 | Director | 0.9 M of 28.5 M |
||
| International Frontier Resources Corp | 021-282817 | Executive Officer | 0.1 M of 0.1 M |
||
| International Frontier Resources Corp | 021-253621 | Director | 0.1 M of 0.2 M |
||
| Neurogesx Inc | 021-187469 | Director | 0.7 M of 0.7 M |
||
| Kalobios Pharmaceuticals Inc | 021-178560 | Director | 17.0 M of 17.0 M |
||
| Neurogesx Inc | 021-175897 | Director | 1.0 M of 1.0 M |
||
| Neurogesx Inc | 021-173081 | Director | 3.0 M of 3.0 M |
||
| Neurogesx Inc | 021-164574 | Director | 1.4 M of 1.4 M |
||
| Neurogesx Inc | 021-163898 | Director | 20.2 M of 20.2 M |
||